These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23680908)

  • 1. Association of Chlamydia trachomatis infection and herpes simplex virus type 2 serostatus with genital human papillomavirus infection in men: the HPV in men study.
    Alberts CJ; Schim van der Loeff MF; Papenfuss MR; da Silva RJ; Villa LL; Lazcano-Ponce E; Nyitray AG; Giuliano AR
    Sex Transm Dis; 2013 Jun; 40(6):508-15. PubMed ID: 23680908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study.
    Karlsson R; Jonsson M; Edlund K; Evander M; Gustavsson A; Bodén E; Rylander E; Wadell G
    Sex Transm Dis; 1995; 22(2):119-27. PubMed ID: 7624813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Chlamydia trachomatis and herpes simplex virus type 1 or 2 in cervical samples in human papilloma virus (HPV)-positive and HPV-negative women.
    Finan RR; Musharrafieh U; Almawi WY
    Clin Microbiol Infect; 2006 Sep; 12(9):927-30. PubMed ID: 16882302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of sexually transmitted infections over 44 years - A cross-sectional study in Sweden.
    Andersson N; Waterboer T; Nylander E; Idahl A
    Int J STD AIDS; 2024 Aug; 35(9):696-702. PubMed ID: 38659325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Frequency of human papillomavirus-herpes simplex-cytomegalovirus and Chlamydia trachomatis infection in genital tracts of sexual partners].
    Behrendt M; Kamińska J; Cymerys Z; Kwaśniewska A; Zimna K; Gozdzicka-Józefiak A; Kedzia H; Semczuk M
    Ginekol Pol; 1998 Jun; 69(6):389-93. PubMed ID: 9695349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer.
    Smith JS; Herrero R; Bosetti C; Muñoz N; Bosch FX; Eluf-Neto J; Castellsagué X; Meijer CJ; Van den Brule AJ; Franceschi S; Ashley R;
    J Natl Cancer Inst; 2002 Nov; 94(21):1604-13. PubMed ID: 12419786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalences of herpes simplex virus type 2, five oncogenic human papillomaviruses, and Chlamydia trachomatis in Katowice, Poland.
    Görander S; Lagergård T; Romanik M; Viscidi RP; Martirosian G; Liljeqvist JA
    Clin Vaccine Immunol; 2008 Apr; 15(4):675-80. PubMed ID: 18287578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of prevalent HPV and STI co-infections and associated factors among HIV-negative young Western Cape, South African women: the EVRI trial.
    Menezes LJ; Pokharel U; Sudenga SL; Botha MH; Zeier M; Abrahamsen ME; Glashoff RH; Engelbrecht S; Schim van der Loeff MF; van der Laan LE; Kipping S; Taylor D; Giuliano AR
    Sex Transm Infect; 2018 Feb; 94(1):55-61. PubMed ID: 28490581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of a multi-epitope protein vaccine against herpes simplex virus, human papillomavirus and Chlamydia trachomatis as the main causes of sexually transmitted diseases.
    Dorosti H; Eskandari S; Zarei M; Nezafat N; Ghasemi Y
    Infect Genet Evol; 2021 Dec; 96():105136. PubMed ID: 34775078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Y chromosome DNA in cervicovaginal self-collected samples of childbearing age women: Implications for epitheliotropic sexually transmitted infections?
    Silva J; Cerqueira F; Medeiros R
    Life Sci; 2015 Oct; 139():62-8. PubMed ID: 26281916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genital infections and risk of premature rupture of membranes in Mulago Hospital, Uganda: a case control study.
    Nakubulwa S; Kaye DK; Bwanga F; Tumwesigye NM; Mirembe FM
    BMC Res Notes; 2015 Oct; 8():573. PubMed ID: 26475265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Chlamydia trachomatis and herpes simplex virus 2 in cervical carcinoma associated with human papillomavirus detected in paraffin-sectioned samples.
    Kwaśniewska A; Korobowicz E; Zdunek M; Skoczyński M; Kwaśniewski W; Daniłoś J; Goździcka-Józefiak A
    Eur J Gynaecol Oncol; 2009; 30(1):65-70. PubMed ID: 19317260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of active infection by herpes simplex virus type 2 in patients with high-risk human papillomavirus infection: A cross-sectional study.
    Bahena-Román M; Sánchez-Alemán MA; Contreras-Ochoa CO; Lagunas-Martínez A; Olamendi-Portugal M; López-Estrada G; Delgado-Romero K; Guzmán-Olea E; Madrid-Marina V; Torres-Poveda K
    J Med Virol; 2020 Aug; 92(8):1246-1252. PubMed ID: 31925791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus type 2 in Brazil: seroepidemiologic survey.
    Da Rosa-Santos OL; Gonçalves Da Silva A; Pereira AC
    Int J Dermatol; 1996 Nov; 35(11):794-6. PubMed ID: 8915732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clustering of seropositivities for sexually transmitted infections.
    Silins I; Tedeschi RM; Kallings I; Dillner J
    Sex Transm Dis; 2002 Apr; 29(4):207-11. PubMed ID: 11912461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating HIV Prevention Programs: Herpes Simplex Virus Type 2 Antibodies as Biomarker for Sexual Risk Behavior in Young Adults in Resource-Poor Countries.
    Behling J; Chan AK; Zeh C; Nekesa C; Heinzerling L
    PLoS One; 2015; 10(5):e0128370. PubMed ID: 26010772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydia trachomatis and herpes simplex virus 2 infection in vulvar intraepithelial neoplasia associated with human papillomavirus.
    Kwaśniewska A; Korobowicz E; Visconti J; Zdunek M; Szymańiski M; Goździcka-Józefiak A
    Eur J Gynaecol Oncol; 2006; 27(4):405-8. PubMed ID: 17009637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of Chlamydia trachomatis, herpes simplex 2, Epstein-Barr virus, hepatitis C and associated factors among a cohort of men ages 18-70 years from three countries.
    Rahman S; Wathington D; Waterboer T; Pawlita M; Villa LL; Lazcano-Ponce E; Willhauck-Fleckenstein M; Brenner N; Giuliano AR
    PLoS One; 2021; 16(6):e0253005. PubMed ID: 34157055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study.
    Sutcliffe S; Giovannucci E; Gaydos CA; Viscidi RP; Jenkins FJ; Zenilman JM; Jacobson LP; De Marzo AM; Willett WC; Platz EA
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1573-80. PubMed ID: 17684131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of genital human papillomavirus infection in a female adolescent population.
    Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
    Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.